CD4 and neoplasm: GITR (glucocorticoid-induced tumour-necrosis-factor-receptor-related protein) is a costimulatory receptor that has a dual anti-tumour effect by promoting the survival and expansion of activated T cells and simultaneously inhibiting the activity of the CD4+CD25+ regulatory Tregs cell population in tumours [527].